PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways
出版年份 2017 全文链接
标题
PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-11-07
DOI
10.1038/s41598-017-14843-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study
- (2016) C. J. Morrow et al. ANNALS OF ONCOLOGY
- Efficacy of pemetrexed plus platinum doublet chemotherapy as first-line treatment for advanced nonsquamous non-small-cell-lung cancer: a systematic review and meta-analysis
- (2016) Yi-Ming Ni et al. OncoTargets and Therapy
- MiRNA-based therapeutic intervention of cancer
- (2015) Srivatsava Naidu et al. Journal of Hematology & Oncology
- The Transcription Factor C-Myc Suppresses MiR-23b and MiR-27b Transcription during Fetal Distress and Increases the Sensitivity of Neurons to Hypoxia-Induced Apoptosis
- (2015) Qun Chen et al. PLoS One
- A set of NF-κB–regulated microRNAs induces acquired TRAIL resistance in Lung cancer
- (2015) Young-Jun Jeon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC
- (2015) Pooja Joshi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRβ Aptamer
- (2014) Simona Camorani et al. MOLECULAR THERAPY
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Mind the IQGAP
- (2013) Berta Sanchez-Laorden et al. CANCER CELL
- p53-Induced miR-15a/16-1 and AP4 Form a Double-Negative Feedback Loop to Regulate Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
- (2013) Lei Shi et al. CANCER RESEARCH
- miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts
- (2013) Loredana Pellegrino et al. NUCLEIC ACIDS RESEARCH
- Epidemiology of Lung Cancer
- (2013) Carole Ridge et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
- (2012) Pasi A Jänne et al. LANCET ONCOLOGY
- Stromal Platelet-Derived Growth Factor Receptor (PDGFR ) Provides a Therapeutic Target Independent of Tumor Cell PDGFR Expression in Lung Cancer Xenografts
- (2012) D. E. Gerber et al. MOLECULAR CANCER THERAPEUTICS
- The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α
- (2012) Shu Zhu et al. NATURE MEDICINE
- Inhibition of Ras for cancer treatment: the search continues
- (2011) Antonio T Baines et al. Future Medicinal Chemistry
- Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
- (2011) Carol Kilkenny et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
- (2011) N. Sunaga et al. MOLECULAR CANCER THERAPEUTICS
- Guidelines for the welfare and use of animals in cancer research
- (2010) P Workman et al. BRITISH JOURNAL OF CANCER
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
- (2010) Alexa B. Turke et al. CANCER CELL
- NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target
- (2010) Wenshu Chen Frontiers in Bioscience-Landmark
- A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens
- (2010) John D. Hainsworth et al. Journal of Thoracic Oncology
- The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner
- (2010) E. W. Joseph et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
- (2009) Etienne Meylan et al. NATURE
- Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
- (2008) S. Yano et al. CANCER RESEARCH
- Mutations in the Phosphatidylinositol-3-Kinase Pathway Predict for Antitumor Activity of the Inhibitor PX-866 whereas Oncogenic Ras Is a Dominant Predictor for Resistance
- (2008) N. T. Ihle et al. CANCER RESEARCH
- Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells
- (2008) Tom Donnem et al. Journal of Thoracic Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now